Transforming Biomarker Development with Exceptional Responders.

about

Transforming Biomarker Development with Exceptional Responders.

Item

http://www.wikidata.org/entity/Q50138587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Transforming Biomarker Development with Exceptional Responders.

@en

Transforming Biomarker Development with Exceptional Responders.

@nl

type

Item

label

Transforming Biomarker Development with Exceptional Responders.

@en

Transforming Biomarker Development with Exceptional Responders.

@nl

prefLabel

Transforming Biomarker Development with Exceptional Responders.

@en

Transforming Biomarker Development with Exceptional Responders.

@nl

P1476

Transforming Biomarker Development with Exceptional Responders.

@en

P2093

Barry S Taylor

http://www.w3.org/2001/XMLSchema#string

Philip Jonsson

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequencing identifies a basis for everolimus sensitivity

Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Response and acquired resistance to everolimus in anaplastic thyroid cancer

Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Implementing Genome-Driven Oncology.

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.

Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report.

P304

3-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRECAN.2017.11.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29413420

http://www.w3.org/2001/XMLSchema#string

P932

5806204

http://www.w3.org/2001/XMLSchema#string